» Articles » PMID: 30621912

Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms

Overview
Journal Trends Neurosci
Specialty Neurology
Date 2019 Jan 10
PMID 30621912
Citations 288
Authors
Affiliations
Soon will be listed here.
Abstract

The mesolimbic hypothesis has been a central dogma of schizophrenia for decades, positing that aberrant functioning of midbrain dopamine projections to limbic regions causes psychotic symptoms. Recently, however, advances in neuroimaging techniques have led to the unanticipated finding that dopaminergic dysfunction in schizophrenia is greatest within nigrostriatal pathways, implicating the dorsal striatum in the pathophysiology and calling into question the mesolimbic theory. At the same time our knowledge of striatal anatomy and function has progressed, suggesting new mechanisms via which striatal dysfunction may contribute to the symptoms of schizophrenia. This Review draws together these developments, to explore what they mean for our understanding of the pathophysiology, clinical manifestations, and treatment of the disorder.

Citing Articles

Neurotransmitters' white matter mapping unveils the neurochemical fingerprints of stroke.

Alves P, Nozais V, Hansen J, Corbetta M, Nachev P, Martins I Nat Commun. 2025; 16(1):2555.

PMID: 40089467 DOI: 10.1038/s41467-025-57680-2.


Exploring the Relationship Between Psychiatric Illness and Dermatological Disorders: A Narrative Review.

Kaye A, Islam R, Castine A, Wester G, Barham W, Nguyen C Cureus. 2025; 17(2):e78731.

PMID: 40065888 PMC: 11892542. DOI: 10.7759/cureus.78731.


Fine-tuning of dopamine receptor signaling with aripiprazole counteracts ketamine's dissociative action, but not its antidepressant effect.

Nakatsuka D, Suwa T, Deguchi Y, Fujita Y, Tashima R, Ohnami S Transl Psychiatry. 2025; 15(1):77.

PMID: 40057507 PMC: 11890785. DOI: 10.1038/s41398-025-03284-9.


Pharmacological reduction of reverse-translated hippocampal hyperactivity in mouse: relevance for psychosis.

Dybowski F, Scott D, Tamminga C Neuropsychopharmacology. 2025; .

PMID: 40016366 DOI: 10.1038/s41386-025-02077-4.


Neurofind: using deep learning to make individualised inferences in brain-based disorders.

Vieira S, Baecker L, Pinaya W, Garcia-Dias R, Scarpazza C, Calhoun V Transl Psychiatry. 2025; 15(1):69.

PMID: 40016187 PMC: 11868583. DOI: 10.1038/s41398-025-03290-x.


References
1.
Cazorla M, de Carvalho F, Chohan M, Shegda M, Chuhma N, Rayport S . Dopamine D2 receptors regulate the anatomical and functional balance of basal ganglia circuitry. Neuron. 2014; 81(1):153-64. PMC: 3899717. DOI: 10.1016/j.neuron.2013.10.041. View

2.
Sterzer P, Adams R, Fletcher P, Frith C, Lawrie S, Muckli L . The Predictive Coding Account of Psychosis. Biol Psychiatry. 2018; 84(9):634-643. PMC: 6169400. DOI: 10.1016/j.biopsych.2018.05.015. View

3.
Egerton A, Chaddock C, Winton-Brown T, Bloomfield M, Bhattacharyya S, Allen P . Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort. Biol Psychiatry. 2013; 74(2):106-12. DOI: 10.1016/j.biopsych.2012.11.017. View

4.
Mizrahi R, Agid O, Borlido C, Suridjan I, Rusjan P, Houle S . Effects of antipsychotics on D3 receptors: a clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO. Schizophr Res. 2011; 131(1-3):63-8. DOI: 10.1016/j.schres.2011.05.005. View

5.
Lerner T, Shilyansky C, Davidson T, Evans K, Beier K, Zalocusky K . Intact-Brain Analyses Reveal Distinct Information Carried by SNc Dopamine Subcircuits. Cell. 2015; 162(3):635-47. PMC: 4790813. DOI: 10.1016/j.cell.2015.07.014. View